Clinical Trials Directory

Trials / Completed

CompletedNCT00844792

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

A Randomized, Double-Blind Study of Combination Vitamin E, Selenium and Lycopene vs. Placebo in Men Undergoing Radical Prostatectomy for Prostate Cancer

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth and prostate cancer aggressiveness.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin ETwice a day with meals. Lycopene - 20 mg, Vitamin D3 - 200 IU, Selenium - 100 mcg, Green Tea Extract - 75 mg, Vitamin E - 50 IU
DRUGPlaceboTwice a day with meals.

Timeline

Start date
2008-10-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2009-02-16
Last updated
2017-10-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00844792. Inclusion in this directory is not an endorsement.